Annotation Detail for NUBP2
Basic Information
Top
| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of NUBP2 mRNA | affects expression | 21346803
|
| C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of NUBP2 mRNA | affects expression | 21346803
|
| C014347 |
decitabine |
decitabine results in increased expression of NUBP2 mRNA | increases expression | 17908484
|
| D015735 |
Mifepristone |
Mifepristone results in increased expression of NUBP2 mRNA | increases expression | 17584828
|
| D018038 |
Sodium Selenite |
Sodium Selenite results in increased expression of NUBP2 mRNA | increases expression | 18175754
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D001943 |
Breast Neoplasms |
|
decitabine |
2.54 | 18320071 19208741 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
3.09 | 16705839 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
3.09 | 16705839 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
2.67 | 19215824 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
3.00 | 6135515 |
| MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
5.24 | 15894690 |
| MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
2.38 | 17616700 |
| MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.10 | 18981723 |
| MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
12.56 | 18551238 |
| MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
12.56 | 18551238 |
| MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
4.10 | 16285004 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
6.77 | 18551238 21346803 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
6.77 | 21346803 18551238 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
6.77 | 15131321 |
| MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
5.73 | 19294695 |
| MESH:D004715 |
Endometriosis |
|
Mifepristone |
4.71 | 16134523 |
| MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
3.71 | 19215824 |
| MESH:D007248 |
Infertility, Male |
|
decitabine |
3.42 | 17581917 |
| MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
3.49 | 14714311 |
| MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
8.39 | 16705839 |
| MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
8.39 | 16705839 |
| MESH:D007938 |
Leukemia |
|
decitabine |
3.22 | 18980019 19235587 |
| MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
4.37 | 17236224 19117987 18454857 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
2.42 | 19387464 17679729 18704418 18460780 18206229 19010910 |
| MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
6.07 | 18055864 |
| MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
2.25 | 7678174 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
2.74 | 6135515 2876786 2876784 |
| MESH:D008223 |
Lymphoma |
|
decitabine |
3.66 | 19470736 |
| MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
4.46 | 14737004 |
| MESH:D008545 |
Melanoma |
|
decitabine |
2.28 | 17785578 16505122 |
| MESH:D009101 |
Multiple Myeloma |
|
decitabine |
3.59 | 18172295 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
3.56 | 18608210 19010910 16882708 19157545 |
| MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
12.21 | 18551238 |
| MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
12.21 | 7678174 18551238 |
| MESH:D009369 |
Neoplasms |
|
decitabine |
2.86 | 17925555 19116145 19470736 |
| MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
10.06 | 16049721 12819281 |
| MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
10.06 | 16049721 |
| MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
5.55 | 19331143 19259094 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Mifepristone |
5.55 | 16525653 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
2.86 | 19294695 |
| MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
5.21 | 17616702 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
3.34 | 18760546 |
| MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
4.81 | 19155313 |
| MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
6.65 | 18551238 |
| MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
6.65 | 18551238 |
| MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
2.10 | 19037991 |
| MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
3.60 | 17967635 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
9.02 | 16049721 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
9.02 | 16049721 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
9.02 | 19087683 17616700 |
| MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
13.86 | 10091137 |
| MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
13.86 | 10091137 |
| MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
5.52 | 17785578 |
Related Pathway Information